Leaving aside the Imaginary Property issue, most costs of "R&D" costs are definitely on the "D" side: it's all those clinical trials to obtain FDA certification that make pharmaceuticals so expensive. And when something doesn't get a pass, that's tens of millions of dollars spent with no possibility to recoup costs.

That said, the pharmaceutical industry has never been hurting for profit every quarter-end: their TV marketing makes sure of that.